BMPBTC
Brother Music Platform / Bitcoin
crypto

Hi, I assume you're going to buy on the Swiss exchange if you're mentioning CHF. Otherwise, the US ticker is CSBTF. To be clear, I'm not in the medical industry but am deeply versed in the science and medical side.
I did my DD on the science behind it and its effects on mesenchymal cell differentiation and macrophage polarization (osteoimmunology) and whatnot over a year ago. I'm throwing around technical terms like mesenchymal cells just to show how deep the science on these products goes. It's my understanding that their product is becoming very competitive across the spine landscape. Some surgeons are blown away by how quickly it begins to solidify. The fusion rates are great, and those who work with the platform are very satisfied with the outcomes. That being said...
These are the current methods for spinal fusion:
* **Autograft** (patient's own bone, usually harvested from the hip), considered the gold standard
* **Allograft** (donor bone from cadavers)
* **DBM** (demineralized bone matrix)
* **Cellular allografts** (donor bone with live cells)
* **BMP** (bone morphogenetic protein to stimulate bone growth, made by Medtronic) This product is riddled with a black box warning and lawsuits BTW. They use this product when they have fusion surgeries that could be at an elevated risk of failure. I'm mentioning this because I'm assuming Medtronic is looking for a substitute like Magnetos
* **Synthetic ceramic grafts** like older versions of biphasic calcium phosphate (BCP)
Preliminarily speaking, it sounds like the success rates are higher with MagnetOs than autograft, which is kind of a big deal. This is coming out of their reporting on the MAXA trial, which if I recall was fewer than 100 patients. They claim an 80% fusion rate with MagnetOs versus 37% for autograft in smokers. It's challenging to really take that at face value since data can always be framed to look good, but the science behind it sounds very solid...
I expect this platform to be more widely adopted across the landscape thanks to the 5-year partnership with Medtronic. I assume they're interested in the product to offer a more complete orthobiologics portfolio and or to find a replacement. With all that, I'm speculating an acquisition in the next few years once it's clear it's the sexy new kid on the block (I think it is). If anyone can chime in on acquisition outcomes in the industry following exclusive partnerships, that would be great. They also have not made public the specifics on Kuros / Medtronic partnership since Kuros is reliant on their sales force for scaling.
My bull case for the stock by 2028 is $60-70 USD a share. That is just my gut and I have only my instincts to rest on. I trade as a very passionate part time hobby, not professionally for full disclosure to who you're talking to on the internet.
The medical industry is a fantastic place to burn money unless you want to deeply break into their trials and the science.
TDLR: I like MagnetO's and think it will do great things for Kuros long term.

Hi, I assume you're going to buy on the Swiss exchange if you're mentioning CHF. Otherwise, the US ticker is CSBTF. To be clear, I'm not in the medical industry but am deeply versed in the science and medical side.
I did my DD on the science behind it and its effects on mesenchymal cell differentiation and macrophage polarization (osteoimmunology) and whatnot over a year ago. I'm throwing around technical terms like mesenchymal cells just to show how deep the science on these products goes. It's my understanding that their product is becoming very competitive across the spine landscape. Some surgeons are blown away by how quickly it begins to solidify. The fusion rates are great, and those who work with the platform are very satisfied with the outcomes. That being said...
These are the current methods for spinal fusion:
* **Autograft** (patient's own bone, usually harvested from the hip), considered the gold standard
* **Allograft** (donor bone from cadavers)
* **DBM** (demineralized bone matrix)
* **Cellular allografts** (donor bone with live cells)
* **BMP** (bone morphogenetic protein to stimulate bone growth, made by Medtronic) This product is riddled with a black box warning and lawsuits BTW. They use this product when they have fusion surgeries that could be at an elevated risk of failure. I'm mentioning this because I'm assuming Medtronic is looking for a substitute like Magnetos
* **Synthetic ceramic grafts** like older versions of biphasic calcium phosphate (BCP)
Preliminarily speaking, it sounds like the success rates are higher with MagnetOs than autograft, which is kind of a big deal. This is coming out of their reporting on the MAXA trial, which if I recall was fewer than 100 patients. They claim an 80% fusion rate with MagnetOs versus 37% for autograft in smokers. It's challenging to really take that at face value since data can always be framed to look good, but the science behind it sounds very solid...
I expect this platform to be more widely adopted across the landscape thanks to the 5-year partnership with Medtronic. I assume they're interested in the product to offer a more complete orthobiologics portfolio and or to find a replacement. With all that, I'm speculating an acquisition in the next few years once it's clear it's the sexy new kid on the block (I think it is). If anyone can chime in on acquisition outcomes in the industry following exclusive partnerships, that would be great. They also have not made public the specifics on Kuros / Medtronic partnership since Kuros is reliant on their sales force for scaling.
My bull case for the stock by 2028 is $60-70 USD a share. That is just my gut and I have only my instincts to rest on. I trade as a very passionate part time hobby, not professionally for full disclosure to who you're talking to on the internet.
The medical industry is a fantastic place to burn money unless you want to deeply break into their trials and the science.
TDLR: I like MagnetO's and think it will do great things for Kuros long term.